Finally, we can indicate that TGFB1 is a marker of poor prognosis in brain tumors and correlates with the expression of HIFs, ectonucleotidases, and the ADORA3 gene involved in purinergic signaling in GB. This evidence concerns the gene ADORA3 and brain neoplasm.